PMC:7377212 / 1514-1793 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T32","span":{"begin":8,"end":17},"obj":"NCBITaxon:2"},{"id":"T33","span":{"begin":52,"end":75},"obj":"UBERON:0001558"},{"id":"T34","span":{"begin":76,"end":81},"obj":"NCBITaxon:10239"},{"id":"T35","span":{"begin":154,"end":162},"obj":"SP_7"},{"id":"T36","span":{"begin":172,"end":185},"obj":"CHEBI:35718;CHEBI:35718"},{"id":"T37","span":{"begin":220,"end":226},"obj":"NCBITaxon:4751"},{"id":"T38","span":{"begin":255,"end":263},"obj":"SP_7"},{"id":"T23433","span":{"begin":8,"end":17},"obj":"NCBITaxon:2"},{"id":"T48068","span":{"begin":52,"end":75},"obj":"UBERON:0001558"},{"id":"T57817","span":{"begin":76,"end":81},"obj":"NCBITaxon:10239"},{"id":"T8958","span":{"begin":154,"end":162},"obj":"SP_7"},{"id":"T86360","span":{"begin":172,"end":185},"obj":"CHEBI:35718;CHEBI:35718"},{"id":"T64802","span":{"begin":220,"end":226},"obj":"NCBITaxon:4751"},{"id":"T86299","span":{"begin":255,"end":263},"obj":"SP_7"}],"text":"lity of bacterial co-infection as a complication of lower respiratory tract viral infection; for example, a recent review found that 72% of patients with COVID-19 received antimicrobial therapy [3]. However, the risk of fungal co-infection, in particular COVID-19 associated pulm"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T3","span":{"begin":52,"end":75},"obj":"Body_part"}],"attributes":[{"id":"A3","pred":"fma_id","subj":"T3","obj":"http://purl.org/sig/ont/fma/fma45662"}],"text":"lity of bacterial co-infection as a complication of lower respiratory tract viral infection; for example, a recent review found that 72% of patients with COVID-19 received antimicrobial therapy [3]. However, the risk of fungal co-infection, in particular COVID-19 associated pulm"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T4","span":{"begin":52,"end":75},"obj":"Body_part"},{"id":"T5","span":{"begin":58,"end":75},"obj":"Body_part"}],"attributes":[{"id":"A4","pred":"uberon_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/UBERON_0001558"},{"id":"A5","pred":"uberon_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/UBERON_0000065"}],"text":"lity of bacterial co-infection as a complication of lower respiratory tract viral infection; for example, a recent review found that 72% of patients with COVID-19 received antimicrobial therapy [3]. However, the risk of fungal co-infection, in particular COVID-19 associated pulm"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T33","span":{"begin":21,"end":30},"obj":"Disease"},{"id":"T34","span":{"begin":76,"end":91},"obj":"Disease"},{"id":"T35","span":{"begin":82,"end":91},"obj":"Disease"},{"id":"T36","span":{"begin":154,"end":162},"obj":"Disease"},{"id":"T37","span":{"begin":230,"end":239},"obj":"Disease"},{"id":"T38","span":{"begin":255,"end":263},"obj":"Disease"}],"attributes":[{"id":"A33","pred":"mondo_id","subj":"T33","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A34","pred":"mondo_id","subj":"T34","obj":"http://purl.obolibrary.org/obo/MONDO_0005108"},{"id":"A35","pred":"mondo_id","subj":"T35","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A36","pred":"mondo_id","subj":"T36","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A37","pred":"mondo_id","subj":"T37","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A38","pred":"mondo_id","subj":"T38","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"lity of bacterial co-infection as a complication of lower respiratory tract viral infection; for example, a recent review found that 72% of patients with COVID-19 received antimicrobial therapy [3]. However, the risk of fungal co-infection, in particular COVID-19 associated pulm"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T13","span":{"begin":34,"end":35},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T14","span":{"begin":52,"end":75},"obj":"http://purl.obolibrary.org/obo/UBERON_0001558"},{"id":"T15","span":{"begin":106,"end":107},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"lity of bacterial co-infection as a complication of lower respiratory tract viral infection; for example, a recent review found that 72% of patients with COVID-19 received antimicrobial therapy [3]. However, the risk of fungal co-infection, in particular COVID-19 associated pulm"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T2","span":{"begin":172,"end":185},"obj":"Chemical"}],"attributes":[{"id":"A2","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_33281"}],"text":"lity of bacterial co-infection as a complication of lower respiratory tract viral infection; for example, a recent review found that 72% of patients with COVID-19 received antimicrobial therapy [3]. However, the risk of fungal co-infection, in particular COVID-19 associated pulm"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T2","span":{"begin":76,"end":91},"obj":"http://purl.obolibrary.org/obo/GO_0016032"}],"text":"lity of bacterial co-infection as a complication of lower respiratory tract viral infection; for example, a recent review found that 72% of patients with COVID-19 received antimicrobial therapy [3]. However, the risk of fungal co-infection, in particular COVID-19 associated pulm"}